% | $
Quotes you view appear here for quick access.

Isis Pharmaceuticals, Inc. Message Board

  • stg696 stg696 May 21, 2013 2:17 PM Flag

    It's good to be a share holder

    - Quality Pipeline
    - Substantial upcoming milestone payments
    - Continual phase study reports (Lets hope for good news)
    - Undervalued potential

    Lets not forget the patents owned for this new form of life saving drugs. Still at $22 - $24 at year end, We'll see what happens when Kynamro gets into patients hands. Took a very small risk and sold a few June $21 puts yesterday. Money where my mouth is, believe the stock stays at least in the $20 range.

    Again, congrats to those who purchased shares last week. Doesn't it feel good to own something that's best of breed with a bright future :)

    Curious what the rest of the actual stock holders think.

    Sentiment: Buy

66.94-0.38(-0.56%)Jun 1 4:00 PMEDT